Clinical Trials Directory

Trials / Completed

CompletedNCT00141973

Time Course of Procalcitonin and C Reactive Protein in Septic Patients Under Treatment With Corticosteroids

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
Ospedale Regionale Bellinzona e Valli · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A systemic treatment with corticosteroids has been advocated for various bacterial infectious diseases. Since the production of CRP is down-regulated by corticosteroids, a smaller increase or a more rapid decrease of this acute phase protein will: 1. suggest attenuated systemic inflammation, but 2. does not necessarily reflect adequate therapy of the infection. For several reasons (good diagnostic tool for sepsis, induction not decreased by immunosuppressive therapy), procalcitonin could be a better marker for activity of sepsis in patients under corticosteroids. As this issue has not yet been examined the investigators will prospectively study the time-course of PTC and CRP in a well-defined septic patient group, that in adjunction to antibiotic therapy also received systemic corticosteroid treatment and compare it to a similar group without corticosteroid treatment.

Conditions

Timeline

Start date
2004-11-01
Completion
2005-12-01
First posted
2005-09-02
Last updated
2008-05-14

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00141973. Inclusion in this directory is not an endorsement.